全球流体管理设备市场 – 行业趋势及 2029 年预测

 流体管理设备市场分析及规模

液体管理是任何住院患者护理的重要组成部分，可通过液体管理设备（如输液治疗产品）解决。液体可通过静脉通路等替代给药途径直接输送到血管系统。液体管理系统可执行多种功能，包括液体灌注、缺陷控制、液体冷冻和液体过滤等。由于医疗保健行业的技术发展不断进步，以及微创手术的增加，全球液体管理系统市场预计将增长。

Data Bridge Market Research 分析，流体管理设备市场在 2021 年为 124.2 亿美元，预计到 2029 年将达到 198 亿美元，在 2022 年至 2029 年的预测期内复合年增长率为 6%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

流体管理设备市场范围和细分

Market Definition

Fluid management equipment is an essential component of any hospitalised patient's care, which can be addressed with fluid management equipment such as infusion therapy products. Fluids can be delivered directly to the vascular system via alternative routes of administration such as intravenous access. Fluid management is an important part of junior doctor prescribing, whether working on a surgical firm with a nil-by-mouth patient or on a care of the elderly firm with a dehydrated patient.

Global Fluid Management Equipment Market Dynamics

Drivers

• Growing prevalence of cardiovascular diseases to drive the demand

The growing prevalence of cardiovascular diseases around the world is the primary driver of the market. For instance, according to a report published by the Centers for Disease Control and Prevention (CDC) in 2021, more than 795,000 people in the United States suffer from stroke each year. One in every 610,000 people suffers from a stroke for the first time. Ischemic strokes account for approximately 87.0% of all strokes. Similarly, according to a report published by the Government of the United Kingdom in 2021, approximately 210,800 men were offered screening for aortic aneurysms, with approximately 1,542 aneurysms detected among them and approximately 848 men with large aneurysms referred for surgery. This factor propel the growth of the market.

• Rise in number of dialysis centers across the world will push the growth

Globally, the number of dialysis centres is growing. During the forecast period, this is expected to drive the fluid management equipment market. According to the Centers for Medicare and Medicaid Services, there were 5,698 dialysis centres in the United States in 2010, up from 4,789 in 2005. Furthermore, emerging-market governments are establishing new dialysis centres and improving existing dialysis centres.

Opportunities

• Government initiatives have been a strong driving force

Leading players in the global fluid management equipment market in cpollaboration with the government have taken initiatives to reach as many ESRD patients as possible across all regions by expanding dialysis centres. B. Braun Melsungen AG alone operates over 300 facilities in Europe, Africa, and Asia Pacific. On World Kidney Day, March 9, 2017, Fresenius Medical Care launched a brand new Asia Pacific-wide corporate social responsibility initiative, reaching 6600 children, parents, and caregivers, as well as media, key renal health partners, and government officials.

Restraints/Challenges

• Stringent regulatory approval procedures will create obstructions

Stringent regulatory requirements and the lengthy FDA approval process have discouraged medical device OEMs in the United States such as Asia and Latin America, to launch newer products in the market. The high investment in R&D and clinical trials is currently the most significant barrier for orthopaedic device manufacturers. Slow approval processes increase costs and provide a low return on investment for stakeholders. Increasing competition among players and increasing preferences over simple machines and consolidate equipment and need for cost control to gain competitive lead will obstruct the market's growth rate.

This fluid management equipment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the fluid management equipment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent developments

• In April 2022, Transit Scientific announced the FDA clearance of its XO Cross Support catheter platform for coronary use. The platform is intended to guide and support the guidewire during access to the peripheral or coronary vasculature, to allow wire exchange, and to provide guidance for saline or diagnostic contrast agent administration.
• In February 2022, Medtronic plc announced that the Freezor and Freezor Xtra Cardiac Cryoablation Focal Catheters were the first and only ablation catheters approved by the FDA to treat the growing prevalence of paediatric Atrioventricular Nodal Reentrant Tachycardia (AVNRT).

Global Fluid Management Equipment Market Scope

The fluid management equipment market is segmented on the basis of product, application, end-use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Infusion Therapy Products
• Endoscopic Fluid Management Products
• Renal Fluid Management Products

 Application

• Cardiology
• Urology
• Neurology
• Orthopaedic/Osteology
• Gastroenterology
• Oncology
• Others

End-Use

• Hospitals
• Clinics
• Diagnostics Centres
• Home Care Setting
• Others

Fluid Management Equipment Market Regional Analysis/Insights

The fluid management equipment market is analysed and market size insights and trends are provided by country, product, application, end-use as referenced above.

The countries covered in the fluid management equipment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the fluid management equipment market due to the largest market share, with high incidence rate of the diseases, advancements in healthcare sector supporting in the growth of the market in the region and technologies advancements in healthcare sector.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to changing lifestyles of the populations leading to high incidence of lifestyle diseases and growing number of surgical procedures performed in these regions.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

流体管理设备市场还为您提供详细的市场分析，包括每个国家/地区资本设备医疗保健支出的增长、流体管理设备市场不同类型产品的安装基数、使用生命线曲线的技术的影响以及医疗保健监管情景的变化及其对流体管理设备市场的影响。数据涵盖 2010-2020 年的历史时期。

竞争格局和流体管理设备市场份额分析

流体管理设备市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对流体管理设备市场的关注有关。

流体管理设备市场的一些主要参与者包括：

• 史赛克（美国）
• ICU Medical, Inc.（美国）
• 奥林巴斯株式会社（日本）
• Fresenius Medical Care AG & Co. kGaA（德国）
• CONMED（美国）
• B.Braun SE（德国）
• 百特（美国）
• Ecolab (美国)
• F. Hoffmann-La Roche Ltd（瑞士）
• 美敦力（爱尔兰）
• BD（美国）
• ALCOR Scientific（美国）
• AngioDynamics（美国）
• 康德乐 (美国)
• 史密斯集团有限公司 (英国)
• Zimmer Biomet（美国）
• 卡尔史托斯（德国）
• Richard Wolf GmbH（德国）
• 辉瑞公司（美国）

SKU-55900